Acceleron Awarded $1.5 Million Grant From MDA

Cambridge based Acceleron is forging ahead to advance its muscle strengthening peptide therapeutic, ACE-031, with grant support from the Muscular Dystrophy Foundation, as well as through its recent collaboration with Shire Pharmaceuticals (http://www.xconomy.com/boston/2010/09/28/acceleron-weans-itself-off-vc-continues-its-roll-with-pharma-partner-dollars/).

Click here to read more.

Share this:
Facebooktwittergoogle_plusmailFacebooktwittergoogle_plusmail